Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma
Francesco Lasorsa(University of Bari Aldo Moro), Giuseppe Lucarelli(University of Bari Aldo Moro), Michele Battaglia(Mater Dei Hospital), Martina Milella(University of Bari Aldo Moro), Pasquale Ditonno(University of Bari Aldo Moro), Felice Crocetto(University of Naples Federico II), Monica Rutigliano(University of Bari Aldo Moro), Savio Domenico Pandolfo(University of Salerno), Loreto Gesualdo(Unknown), Simona Simone(University of Bari Aldo Moro), Matteo Ferro(European Institute of Oncology)
Cited by 98
Related Papers
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
|The Lancet|2023|264
The copy number variation landscape of congenital anomalies of the kidney and urinary tract
|Nature Genetics|2018|240
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
|International Journal of Molecular Sciences|2022|190